Warner Chilcott (WCRX)
Add to Watchlists Create an Alert
19.81
-0.19 -0.95%
NASDAQ
May 24, 2:42PM
BATS Real time
Currency in USD
Warner Chilcott Revenue Quarterly YoY Growth:
-13.43% for March 31, 2013Warner Chilcott Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -13.43% |
| Dec. 31, 2012 | -5.26% |
| Sept. 30, 2012 | -7.48% |
| June 30, 2012 | -4.78% |
| March 31, 2012 | -9.51% |
| Dec. 31, 2011 | -6.97% |
| Sept. 30, 2011 | -6.85% |
| June 30, 2011 | -17.85% |
| March 31, 2011 | -0.57% |
| Dec. 31, 2010 | 1.19% |
| Sept. 30, 2010 | 178.2% |
| June 30, 2010 | 225.2% |
| March 31, 2010 | 209.5% |
| Dec. 31, 2009 | 183.0% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
WCRX Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Mylan | 3.02% |
| Actavis | 24.35% |
| Valeant Pharmaceuticals International | 24.79% |
WCRX Revenue Quarterly YoY Growth Rankings
| Overall |
47th percentile 4189 of 8009 |
| Sector |
39th percentile 415 of 687 in Healthcare |
| Industry |
43rd percentile 39 of 69 in Drug Manufacturers - Specialty & Generic |
WCRX Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -17.85% | Jun 2011 |
| Maximum | 225.2% | Jun 2010 |
| Average | 37.98% |
